glp-1 drugs heart failure The effect of receptor agonists on cardiac remodeling in patients with preserved and reduced ejection fraction: a systematic review and meta-analysis | Heart Failure Reviews Glucagon-Like Peptide-1 Agonist Use in
Description
Therefore, there is a need to identify those potential changes and adjust patients medication doses in order to achieve higher efficacy and avoid toxicity.
The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer
88% reduced sugar cravings
GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs
